Organisation & Structure

The General Assembly consists of all members and is the supreme organ of the Network. The General Assembly is responsible for the governing statutes to regulate the day-to-day business.


The Steering Committee is responsible for the activities of the and acts as its decision-making body within the framework set by the General Assembly. The Steering Committee consists of up to eleven representatives: the Chairman, the Coordinator of each Expert Committee, the Coordinator of each Transversal Section and the CEO of the Management Board.

The present Chairman of is Hendrik Scholl . The Management Board is AIBILI, in Coimbra, Portugal. The Management Board functions within the framework set by the Steering Committee.


The Coordinating Centre / Management Board functions are:

A. General management activities:
- Prepare the Network and annual budget
- Provide infrastructural support to the Chairman and Expert Committees
- Coordinate activities with the Steering Committee and any other Committees
- Prepare summaries of committees conference calls and meetings
- Preparation and submission of proposals for EU funding
- Represent the Network with Regulatory Agencies such as EMA
- Promotion (newsletter, website, etc.)


B. Management of Members:

- Application of new members
- Certification of Clinical Sites
- Re-certification of Clinical Sites
- SOP Management (Organizational, Technical and Reading Centres SOPs)

C. Management activities directly related to Clinical Trials:
- Coordinate the submission of abstracts or potential Investigator Initiated Research (IIR) according to internal procedures

- Preparation and submission of IIR for Industry grants or for EU funding

- Assist the Clinical Sites in achieving high recruitment rates and maintain high rates of patients retention

- Coordination and management of IIR


The Expert Committees have a fundamental role in the scientific organization of and cover the following main areas of research:
- Age-Related Macular Degeneration - Coordinator: Francesco Bandello

- Retinal Dystrophies - Coordinator: Hendrik Scholl
- Diabetic Retinopathy & Vascular Diseases - Coordinator: José Cunha-Vaz
- Glaucoma - Coordinator: Francesca Cordeiro
- Anterior Segment - Coordinator: Marie-José Tassignon

- Ocular Surface, Inflammation, Dry-Eye & Allergies - Coordinator: Marc D. de Smet


There are also the following Transversal Sections that work together with the Expert Committees, when applicable:

- Medical Devices - Coordinator: Jorge Alió

- Rare Diseases - Coordinator: Birgit Lorenz

- Reading Centres - Coordinator: Tunde Peto

The Expert Committee and the Transversal Sections will advise the Steering Committee on matters related to the running of clinical research in their scientific area.


The Expert Committees functions are:
- Prepare expert advice for Industry
- Evaluate IIR submitted by Members

- Propose Clinical Trials to Industry or for European Union funding
- Evaluate potential for a specific trial
- Establish Working Groups for:
       - Writing Committees

       - Proposals Evaluation

       - Development of technical SOPs
       - Certification of technicians
       - Educational and training activities
       - Development of databases

Each Expert Committee supervises a Scientific Section with the participation of the subspecialty representatives from each Clinical Site Member. Each Clinical Site will then nominate one representative for each area of interest and expertise. This representative will be part of the chosen Scientific Section.


The Industry Advisory Board advises the Steering Committee in all matters of strategic relevance, particularly pertaining collaborations with Industry. The Industry Advisory Board is composed of individuals or representatives of entities who have given support for the activities of, by invitation of the Steering Committee.


2010 EVICR Network. All rights reserved.